Functional Heart Pacemaker Cells Developed
In a first, scientists have produced functional pacemaker cells from human stem cells, paving the way for alternate, biological pacemaker therapy. The researchers from the McEwen Centre for Regenerative Medicine, University Health Network, used a developmental-biology approach to establish a specific protocol for generating the pacemaker cells. Their work is reported in the journal Nature Biotechnology.
See Also: Pacemaker Checks Help Prevent Stroke
The findings show how human pluripotent stem cells can be coaxed in 21 days to develop into pacemaker cells, which regulate heart beats with electrical impulses. Tests were conducted in rat hearts where these pacemaker cells successfully activated the electrical impulses that trigger the contraction of the heart.
"What we are doing is human biology in a petri dish," explains Dr. Gordon Keller, Director of the McEwen Centre, the senior author, and a trailblazer in generating a wide variety of specialised cells from human stem cells. "We are replicating nature's way of making the pacemaker cell."
Sinoatrial node pacemaker cells are the heart's primary pacemaker, controlling the heartbeat throughout life. Defects in the pacemaker can lead to heart rhythm disorders that are commonly treated by implantation of electronic pacemaker devices. Biological pacemakers represent a promising alternative to electronic pacemakers, overcoming such drawbacks as a lack of hormonal responsiveness and the inability to adapt to changes in heart size in paediatric patients.
The McEwen Centre scientists noted that human clinical trials to test such biological pacemakers are from five to 10 years away, and that the next step is to launch safety and reliability pre-clinical trials on the pacemaker cells.
Still, researchers can use their new technology to produce pacemaker cells from patients suffering from pacemaker dysfunction. They can then use these patient-specific cells to study the "disease in a (petri) dish" and to identify new drugs that will improve their pacemaker function.
Long term, the research team hopes to develop a biological pacemaker to transplant into patients who need an electronic one. These electronic pacemakers can last anywhere from five to 10 years or more – on the average about seven years. If successful, the biological pacemaker holds the promise of a lifelong cure.
Source: University Health Network
Image Credit: University Health Network
Published on : Mon, 19 Dec 2016
The Serie TEE is the first washer-disinfector specially designed for cardiac transesophageal probes . For efficiency of cardiology departments Safe and fully automated, this reliable and fast probe reprocessor offers a complete reprocessing...
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
The Connex® Spot Monitor features an easy-to-use, vivid touchscreen display and provides accurate vital signs measurement including blood pressure averaging, spot checking, interval monitoring and custom scoring across patient populations. The device...
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...
By lifting up the device cover, the FRED PA-1 starts up immediately and guides the rescuer step-by-step during the entire resuscitation process. The FRED PA-1 is available either as semi-automatic or fully automatic device.In its automatic version,...